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The aim of the work was evaluate the effects of testosterone undecanoate (TU) treatment combined 
with moderate physical training on: the estrous cycle, body weight (BW), motor behavior (MB), and 
the morphohistology of the reproductive system, the liver and kidney in rats. Female Wistar rats (180 g 
- 250 g) were divided as follows: sedentary + TU (S + TU), trained + TU (T + TU), sedentary + vehicle 
(S + V), trained + vehicle (T + V). The rats swam 50 min/Day, strapped with a 5% BW load, for 4 weeks. 
During this training, (BW) was monitored daily as well as the estrous cycle (EC) by vaginal smear. The TU  
(15 mg/kg s.c) was administered 3 times/week for 4 weeks. At the end of the study, data on MB, BW 
and morphohistopathological changes in viscera were compiled. The (T + TU) group had on average, a 
higher (BW) in the fourth week compared to the first week, and (BW) higher than (S + V) and (S + TU) 
groups. We noted an interruption in the EC and a decrease in weight of ovaries in animals treated with 
TU. In addition, there was an increase in the relative weight of the heart in groups (T + V) and (T+ TU), 
and kidneys in group (T + TU). Histopathological analysis showed periportal congestion and isolated 
foci of hepatic necrosis in rats with TU. Thus, TU combined with training abolished the EC, promoted 
ovarian atrophy, liver necrosis, cardiac hypertrophy and a decrease in motor activity.
Uniterms: Androgenic anabolic steroids/experimental study. Endurance training. Testosterone 
undecanoate.
O objetivo do trabalho foi avaliar o efeito do tratamento com undecanoato de testosterona (UT) combinado 
ao treinamento físico moderado sobre ciclo estral, peso corporal, estruturas do sistema reprodutor, 
comportamento motor e morfologia hepática e renal em ratas. Ratas Wistar (180 a 250 g) foram divididas 
em: sedentárias + UT (S+UT), treinadas + UT (T+UT), sedentárias + veículo (S+V), treinadas + veículo 
(T+V). As ratas nadaram 50 min/dia com sobrecarga de ~5% do peso corporal por 4 semanas. Durante 
o período de treinamento foi realizado acompanhamento diário do peso corporal (PC) e do ciclo estral 
(CE) pelo esfregaço vaginal. O UT (15 mg/kg s.c.) foi administrado 3x/semana durante 4 semanas. Ao 
final foram avaliados comportamento motor, pesos e alterações histopatológicas de alguns órgãos. O 
grupo T+UT apresentou PC maior na quarta semana do que na primeira, com pesos corporais maiores 
que os grupos S+V e S+UT. Houve interrupção no CE e redução do peso dos ovários nos animais tratados 
com UT. Houve aumento do peso relativo do coração, nos grupos T+V e T+UT, e do peso relativo dos 
rins, no grupo T+UT. A análise histopatológica revelou congestão periportal e focos isolados de necrose 
hepática nas ratas com UT. O UT combinado com treinamento produziu supressão do ciclo estral, atrofia 
ovariana, necrose hepática, hipertrofia cardíaca e redução da atividade motora. 
Unitermos: Esteróides androgênicos anabólicos/estudo experimental. Exercício físico. Undecanoato 
de testosterona.
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INTRODUCTION
Several studies have emphasized the need for 
physical exercise programs in promoting global health, 
due to the positive effect which an active lifestyle has in 
maintaining health, preventing and reducing the number 
of chronic non-communicable diseases, besides promoting 
the quality of life (Matsudo, 2006). On the other hand, the 
professional athletes always seek to break existing records, 
which often leads to the use of banned substances such 
as anabolic androgenic steroids (AAS). In an attempt to 
magnify the results obtained from physical training, ath-
letes and non-athletes use AAS as ergogenic resources to 
improve performance and physical appearance (increased 
muscle mass and tonus) (Perssinen et al., 2002; Maravel et 
al., 2005; Bahrke et al., 2004; Franke et al., 1997). These 
steroids (AAS) are synthetic or natural compounds, similar 
to testosterone, which act directly upon specific types of 
receptors (Maravel et al., 2005; Clarkson et al., 1997), mo-
dulating inseparably both anabolic and androgenic effects 
(Perssinen et al., 2002; Rabkin et al., 2000; Nasrollah et 
al., 2001). Currently, over 60 different types of AAS are 
available for use, varying largely in chemical structure. 
The use of anabolic androgenic steroids (AAS) has 
been the focus of research worldwide, since the adminis-
tration of AAS is often associated with various adverse 
dose-related effects, the most common of which are: 
masculinization in women and children, hypertension, 
atherosclerosis, thrombosis, jaundice, cancer and liver 
cancer, tendon injury, as well as psychiatric and behavioral 
disorders in both sexes (Maravel et al., 2005). Bahrke et 
al. (2004), report infertility and gynecomastia in men, as 
well as liver problems, impotence and hypertrophy of the 
clitoris in women. 
Several clinically used substances can often be em-
ployed to improve athletic performance, as is the case of 
Testosterone Undecanoate (TU), clinically prescribed for 
hormone replacement therapy in men. Several prevalent 
studies on non-prescribable AAS have shown that such  use 
is not restricted to men (Thiblin et al., 2005; Mobin et al., 
2007). However, physiological and behavioral effects of 
AAS are not well understood in women (Clark et al., 1998). 
Although they can be used therapeutically at low 
doses to treat aplastic anemia (Velazquez et al., 2004), 
osteoporosis (Berning et al., 2001; Kilbourne et al., 2007), 
and as antitumor agents in breast cancer (von Bueren et 
al., 2007) in women, the beneficial health effects of such 
doses contrast with the risks associated with excessive 
self-administered doses by women athletes. 
Despite the large number of studies involving AAS 
use, few associate such use with aerobic or endurance 
exercise among the female population. Cadore et al. 
(2008) studied the concentrations of total testosterone, 
free testosterone and cortisol in individuals who trained 
or otherwise. He noted that home values were similarly 
increased after the training protocol. Another fact reported 
in the literature refers to the possibility of AAS use, asso-
ciated with resistance exercise, reducing the effectiveness 
of sleep (Venancio et al., 2008). Furthermore, Lambert et 
al. (1995), studying the effect of AAS treatment on the 
running performance of rats, found that animals treated 
with AAS and subjected to physical training of moderate 
intensity showed an increase in resistance of 41% com-
pared to the group that received saline, while no changes 
were detected in the sedentary groups. 
Considering the frequent use of AAS and their po-
tential health risks, coupled with few studies assessing the 
effects of these drugs in females, the objective of this study 
was to evaluate the effect of Testosterone Undecanoate 
treatment (TU) in rats subjected to swimming in term of: 
body weight, structures of the reproductive system, the es-
trous cycle, motor activity, and histopathological changes 
of heart, liver and kidneys.
METHODS 
Animals 
Experiments were performed on adult female rats 
(N = 32) of the Wistar strain, weighing (180-250 g), obtai-
ned from the laboratory of Research on Medicinal Plants, 
Federal University of Piauí. The animals were kept in 
Bollman cages, each housing four animals with controlled 
room temperature and a light-dark 12/12 h cycle and free 
access to water and food. All procedures complied with the 
ethical standards set by the Brazilian College of Animal 
Experimentation. 
Treatment 
The animals were randomly assigned to four groups, 
each comprising eight animals: sedentary treated with TU, 
trained treated with TU, vehicle-treated sedentary and 
trained but treated with vehicle. Each respective group 
received the Vehicle or AAS, by a subcutaneous injection 
of vegetable oil (0.1 mL/100 g/body weight) or testoste-
rone undecanoate (Androxon® 15 mg/kg), 3x/week for 4 
weeks (Lindqvist et al., 2005). 
Physical training 
The training protocol was adapted from Medeiros et 
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al. (2004), where the rats in the trained groups were sub-
mitted to a 50 min/day swim in a rectangular cylinder with 
water at 28±1 °C (5 days/week), for a period of 4 weeks. 
After the adaptation period to the water, the rats received 
increasing burdens in the form of load weights attached to 
their backs up to the study end-point of  4 weeks, making 
up 5% of body weight. 
Evaluation of motor exploratory behavior (open 
field) 
At the end of the training and treatment, the rats were 
submitted to an exploratory motor capacity evaluation 
(open field) (Burghardt et al., 2004), viewing the feasibi-
lity of its application. The test consisted of placing the rats 
at the center of a square arena (25x75x75 cm) divided into 
nine parts of equal size. To assess exploratory locomotor 
ability, the number of invasions each rat made by crossing 
to another square on four legs during a 5-minute period 
was quantified. 
Monitoring the estrous cycle 
During the administration of testosterone undecano-
ate and physical training we monitored the estrous cycle of 
the animals in all groups, on a daily basis between 17:00hs 
and 18:00hs, by determining the cell types and characte-
ristics in fresh colorless vaginal washes observed under a 
light microscope. These characteristics were categorized 
as: a) the proestrous phase, consisting of nucleated cells, 
b) estrous phase, consisting of cornified epithelial cells, c) 
metestrous, consisting of white blood cells in combination 
with cornified epithelial cells, and d) diestrous phase, con-
sisting of isolated (or grouped) leukocytes  and nucleated 
cells (Thrower et al., 1981). 
Evaluation of weight of tissues: uterus, ovary, 
liver, kidneys and heart 
At the end of the 4 weeks of treatment and training, 
the rats were euthanized under anesthesia with inhaled 
ether, causing pneumothorax, and tissues verified by 
making a midline incision up to the sternal level, opening 
the thoracic cavity and rupturing the diaphragm. The 
uterus, ovaries, liver, kidneys and heart were carefully 
collected and weighed. 
Histological processing and evaluation of liver, 
kidneys and heart 
Sorted fragments of liver, kidneys and heart were 
immersed in a solution of 10% formalin for histological 
processing, and fixed in paraffin. The blocks were cut into 
7mm-thick slices and stained with hematoxylin-eosin for 
histological analysis. Histological evaluation took into 
account the presence of changes such as: 1) inflammatory 
response, 2) periportal hepatic congestion, with foci of 
hepatic necrosis, 3) hyaline sclerosis in renal arterioles 
and kidney degeneration (common in intense physically 
active), and 4) presence of changes in the thickness of 
walls and signs of hypertrophy of myocardial fibers. 
Statistical analysis 
Data were presented as mean±SEM and analyzed 
by a paired t test to compare differences within groups, 
and analysis of variance (ANOVA one way) followed by 
post-hoc test (Tukey) for comparison between groups. The 
level of significance was set at p <0.05. The pathological 
examinations were compared between the groups using the 
Chi-square test (χ2), and a significance level of p <0.05.
RESULTS 
The assessment of body weight showed no signi-
ficant difference between the initial weights of the four 
groups during the first week of training and/or treatment 
(Figure 1). With regard to the weight of the animals on 
the fourth week, there was a significant increase in body 
weight of the trained group treated with TU, compared to 
the sedentary groups with or without treatment with TU 
(p <0.05). The gain in weight during training and/or treat-
ment was noticeable in the trained group treated with TU, 
FIGURE 1 - Effect of treating sedentary (S) or trained (T) 
rats with Testosterone Undecanoate (TU) (15 mg.kg s.c) or 
Vehicle (V) on body weight (g). The (T) group was submitted 
to swimming exercise training for 4 weeks (* p <0.05 as for 
the T+TU group on the fourth week, we conducted one-way 
(ANOVA) followed by Tukey post-hoc, ** p < 0.01 paired t test 
on final weight compared to baseline within the group). The data 
are expressed as mean ± SEM of 8 animals per group.
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which showed significant weight gain between the first 
and fourth weeks of training (p <0.01). 
On monitoring the vaginal cytology daily (for 4 
weeks), we observed that treatment with TU altered the 
estrous cycle by interrupting the estrous (the animals were 
actually anestrus) both in the sedentary and trained group. 
Moreover, physical training through swimming for 4 we-
eks produced no change in either the number or duration 
of estrous cycles (Table I). 
Concerning the corrected weights (g/100g body 
weight) of reproductive organs, although no changes 
were observed in the uterus (Figure 2), the data showed 
an approximate 50% reduction in ovaries of animal groups 
treated with TU compared to those of animals treated with 
vehicle (p<0.001) (Figure 3). 
Figure 4 evidences an increase in cardiac mass 
(p<0.01) in trained groups with/without TU (0.37 ± 0.01 
and 0.41 ± 0.01 g, respectively). There were no significant 
differences in the corrected weights of livers among the 4 
FIGURE 2 - Effect of Testosterone Undecanoate (TU) 
(15 mg.kg s.c) or Vehicle (oil) treatment on the uterine weights 
corrected for body weight (g/100 g) in sedentary and trained rats 
submitted to swimming exercise training for 4 weeks. The data 
are expressed as mean ± SEM of 8 animals/group.
FIGURE 3 - Effect of Testosterone Undecanoate (TU) 
(15 mg.kg s.c) or Vehicle (oil) treatment on the weight of ovaries 
corrected for body weight (g/100g) in sedentary or trained rats 
submitted to swimming exercise training for 4 weeks. The data 
are expressed as mean ± SEM (n = 8) followed by ANOVA and 
post-hoc. * P <0.05 between test groups Sedentary + TU vs 
Sedentary and Trained + TU vs Trained.
TABLE I - Effect of Testosterone Undecanoate (TU) (15 mg.kg s.c) or Vehicle (oil) treatment on the estrous cycle of sedentary rats 
or animals subjected to physical training by swimming for 4 weeks
Number of 
cycles per rats
Duration of the 
cycles (days)
Duration of each phase in the cycle (days)
Groups (n=8) Estrus Metestrus Diestrus Proestrus
Sedentary 4.00 ± 0.00 5.40 ± 0.13 1.3 ± 0.2 1.14 ± 0.17 2.08 ± 0.28 0.80 ± 0.11
Trained 4.12 ± 0.64 5.24 ± 0.54 2.4 ± 0.2 1.10 ± 0.14 2.09 ± 0.15 0.86 ± 0.11
Sedentary + TU 0 0 0 0.12 ± 0.35 21.88 ± 0.35 0
Trained + TU 0 0 0 0 22.00 ± 0.00* 0
The data are expressed as (mean ± SEM of n=8 rats/group). 
* Animals were anestrous throughout the treatment period.
animal groups (3.1 ± 0.13, 3.0 ± 0.17, 3.2 ± 0.12 and 3.6 ± 
0.30 g, respectively), as shown in Figure 5. In Table II, the 
analysis shows periportal hepatic congestion (p <0.05) in 
62.5% of animals in the trained group treated with TU and 
in 50% of the animals from the sedentary group treated 
with TU, and foci of liver necrosis (isolated without an 
inflammatory response) in 62.5% of the groups (trained 
and sedentary) treated with TU. 
The results of the weight of the kidneys, as shown 
in Figure 6, revealed no significant differences in correc-
ted weights between the sedentary groups with/without 
administration of TU, and trained groups without TU 
(0.64 ± 0.02, 0.65 ± 0.01 and 0.64 ± 0.02 g respectively). 
However, the weight of the kidneys of the trained group 
treated with TU was significantly higher than the other 3 
groups (0.71 ± 0.01 g, p <0.05). Moreover, morphological 
changes characterized by degeneration of the kidney were 
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FIGURE 4 - Effect of testosterone undecanoate (TU) (15 mg.kg 
s.c) or Vehicle (oil) treatment on the heart weight corrected for 
body weight (g/100 g) in sedentary or trained rats submitted to 
swimming exercise training for 4 weeks. The data are expressed 
as mean ± SEM (n = 8) followed by ANOVA and post-hoc. 
(# p <0.05 Sedentary vs Trained and *p <0.05 for Trained +TU 
vs Sedentary and Sedentary + TU).
TABLE II - Histopathological changes found in the liver and kidneys of rats treated with Testosterone Undecanoate (TU) (15 mg.kg 
s.c) or Vehicle (oil), with and/or without swimming exercise training for 4 weeks
Liver
Kidney
Groups (n=8)
Hepatic congestion Necrosis
Number % Number % Number %
Sedentary 0 0.0 0 0.0 0 0.0
Sedentary+TU 4 50.0* 5 62.5* 0 0.0
Trained 1 12.5 0 0.0 3 37.5
Trained+TU 5 62.5# 5 62.5# 2 25.0
* P <0.05, Chi-square test (x2) for Sedentary + TU vs Sedentary. 
# P <0.05, Chi-square test (x2) for Trained + TU vs Trained.
FIGURE 5 - Effect of Testosterone Undecanoate (TU) 
(15 mg.kg s.c) or Vehicle (oil) treatment on liver weight 
corrected for body weight (g/100 g) in sedentary or trained rats 
submitted to swimming exercise training for 4 weeks.
found in 25% of the animals in the trained group treated 
with TU, and 37.5% of the trained group without TU. 
Figure 7 presents the results of exploratory motor 
activity on the open field test. There were no significant 
differences between the sedentary + vehicle and trained 
+ vehicle (33.8 ± 13.0 vs 46.6 ± 16.8 invasions ─ Figure 
7A) or between the sedentary + vehicle and sedentary + 
TU (33.8 ± 13.0 vs. 24.0 ± 11.6 invasions ─ Figure 7B). 
However, the trained + TU group showed a significant 
decrease (p <0.05) in exploratory motor activity compared 
to the trained + vehicle group (26.16 ± 12.79 vs 46.6 ± 
16.80 invasions ─ Figure 7C). 
DISCUSSION 
Treating rats with testosterone undecanoate associa-
FIGURE 6 - Effect of testosterone undecanoate (TU) (15 mg.kg 
s.c) or Vehicle (oil) treatment on kidney weight corrected for 
body weight (g/100 g) in sedentary or trained rats submitted to 
swimming exercise training for 4 weeks. The data are expressed 
as mean ± SEM (n = 8) followed by ANOVA and post-hoc. * p 
<0.05, Trained + TU vs Sedentary, Sedentary + TU and Trained.
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ted with moderate physical training for 4 weeks promoted 
gain in weight (p <0.01), which was absent in animals 
treated with TU but not subjected to the exercise program. 
Similarly, no significant weight gain was observed in the 
group which underwent training for 4 weeks without TU. 
According to Cunha et al. (2005a), AAS treatment promotes 
a significant decrease in weight in sedentary animals, which 
does not occur in exercised rats. This finding is explained by 
the changes occurring in physical training, which by itself 
is not enhanced by AAS treatment. This in turn is explai-
ned by the fact that, at excessive concentrations, AAS can 
inhibit growth and weight gain due to decreased appetite, 
electrolyte imbalance and increased lipid oxidation as a re-
sult of increased activity of the enzyme carnitine palmitoyl-
transferase (Lee et al., 2003; Guzman et al., 1991). Another 
relevant issue is the fact that physical training may provoke 
exercise-induced anoxia, which is potentially linked to 
increased blood concentrations of peptide YY, GLP-1 and 
pancreatic polypeptide PP (Martins et al., 2007). 
In an experimental model combining physical trai-
ning and treatment of rats with AAS, Cunha et al. (2005b) 
found increased body weight and altered biochemical fac-
tors in rats submitted to anaerobic training (leaps) which 
had been treated for six weeks with Nandrolone Decanoate 
(DECA). However, in another experimental model using 
isolated forms of AAS, Blarberg et al. (1997), studying the 
effects of 17 α-Methyltestosterone, Methandrostenolone, 
and Nandrolone Decanoate on the estrous cycle, found 
no significant body weight change in animals treated with 
these compounds. Similarly, Clark et al. (1998) found that 
treating rats with Stanozolol for 2 weeks had no significant 
effect on body weight during the study period. 
Regarding the effects of testosterone undecanoate 
treatment on the estrous cycle, vaginal cytology manifes-
ted distinct alterations, characterized principally by the 
absence of the estrous phase in all trained and sedentary 
groups treated with TU. By contrast, the groups of rats 
which did not receive TU had a positive estrous phase, 
with each cycle lasting about five days on average. These 
findings corroborate with the results of other studies which 
have demonstrated that varied isoforms of AAS disrupt the 
vaginal cytology cyclical changes. Blasberg et al. (1997) 
observed that the treatment with 17 α-methyltestosterone, 
methandrostenolone, and nandrolone decanoate at doses 
that mimic those used by human athletes, produced rever-
sible and a dose-dependent sexual receptivity conduct and 
oestrous vaginal cytology in rats over a two-week period. 
During the intervening period, these animals manifested 
lordosis, infrequently accompanied by characteristic dies-
trous phase smears, and the author also observed that the 
effects of treating with Nandrolone Decanoate at a dose of 
7.5 mg / kg on the estrous cycle were longer, where vaginal 
estrous resumed within 2 months of treatment completion.
Regarding the mechanisms involved in these chan-
ges, some authors associate the effects of testosterone 
on the ovaries. In this sense, Clark et al. (1998) suggests 
that the decrease in time of vaginal estrus during two 
weeks of treatment with AAS, as well as the absence of 
estrus (i.e. persistent diestrus) during the recovery period, 
pronounced with testosterone use, could be related to the 
existence of different routes of metabolism of the steroid 
and its relationship to the reproductive function. Triems-
tra et al. (2004) studied the effects of AAS on the female 
reproductive system, noting an inhibitory effect. In other 
studies, where a cessation of vaginal estrus in the presence 
of high concentrations of testosterone was observed, it 
was suggested that such a response could possibly result 
from the degenerative effects of high levels of androgens 
on ovarian granulosa cells (Anderson, 1989; Anderson 
et al., 1987). 
FIGURE 7 - Effect of Testosterone Undecanoate (TU) (15 mg.kg 
s.c) or Vehicle (oil) treatment on motor activity (open field test) 
in sedentary and trained rats submitted to swimming exercise 
training for 4 weeks. The data are expressed as mean ± SEM 
(n = 8) followed by ANOVA and post hoc. * P <0.05 Trained + 
TU vs Trained, box C).
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Furthermore, the use of AAS leads to impaired 
function of the hypothalamic-pituitary-gonadal  system 
(HPG), raising the levels of circulating androgens that 
may reduce the release of gonadotropins through negative 
feedback which (in females ) decreases the secretion of 
estrogen (Harlan et al., 1992; Kao et al., 1975; Strauss et 
al., 1993). According to Bronson (1996), the suppression 
of LH, FHS and of estradiol and cessation of vaginal cycle 
in rats are all associated with chronic treatment with AAS. 
Eklof et al. (2003) reported that the use of anabolic 
steroids in males causes decreased levels of luteinizing 
hormone, follicle-stimulating hormone, as well as a lower 
production of endogenous testosterone and sperm, leading 
to testicular atrophy. Moreover, in rats treated with nan-
drolone decanoate at a dose of 3 mg/kg, the destruction of 
follicular units and absence of Corpora luteum in the ovaries 
have been demonstrated, alongside morphological changes 
in the uterus such as endometrial fibrosis (Gerez et al. 2005). 
Far et al. (2007) showed that administering nandrolone de-
canoate at a dose of 15 mg/kg causes morphological changes 
in uteri of rats associated with suppression of reproductive 
capacity. The results of our study corroborate those repor-
ted in the literature, in that chronic treatment with TU led 
to the suppression of the estrous cycle resulting in ovarian 
atrophy, besides significant reduction of weight, probably 
due to inhibition of HPG and the effects of testosterone on 
the female gonads. The weight, structure and the receptors 
to sex steroids in the uterus were not significantly altered 
among the studied animals, while some studies have repor-
ted no changes with chronic use of AAS. 
Aerobic training per se, has proven to be valuable for 
patients with chronic kidney disease (CKD), promoting an 
increase in oxygen consumption, while moderately intense 
exercise programs can lead to improved quality of life in 
patients with renal failure (Daul et al., 2004; Johansen, 
2005). In this study, we observed renal histopathological 
changes in rats submitted to moderately intense training 
with vehicle, as well as those trained and treated with TU, 
suggesting that in this case treatment with steroids may not 
be interfering with renal morphology. However, intense 
training combined with AAS, as seen in weightlifters, can 
cause kidney damage (Rava et al., 2000). 
Testosterone and its synthetic derivatives, the 
AAS, are known to stimulate muscle protein synthesis 
and enlargement, and recent studies have demonstrated 
better muscle function recovery after injury (Lynch et al., 
2008). However, the use of AAS has adverse effects on the 
cardiac muscle including disintegration of the functional 
syncytium, cardiac rupture, deterioration of cardiac func-
tion and apoptosis (Appell et al. 1983; Cavasin et al. 2006; 
Crisostomo et al., 2006). 
Associating AAS with aerobic exercise promotes 
increased deposition of collagen in the heart, causing 
ventricular remodeling, a phenomenon associated with 
local activation of the renin-angiotensin system (Rocha et 
al., 2007). However, treatment with AAS nandrolone for 
4 weeks does not promote change in the Bezold-Jarisch 
reflex, which increases in relation to the efferent vagal 
pathway (Andrade et al., 2008). 
In the present study we observed increase in cardiac 
mass in both trained groups. However, rats submitted to 
exercise training and pretreated with TU presented greater 
mean heart mass than animals subjected to training alone. 
Published data indicate that chronic use of AAS is direc-
tly related to an increase in number of cardiac myocytes 
(Marsh et al., 1998). According to Trifunovic et al. (1995, 
1998), chronic administration of high doses of anabolic 
androgenic steroids such as nandrolone decanoate, simi-
lar to those used by athletes, attributes to a decrease in 
compliance of the myocardium in the left ventricle, as 
well as changes in contractility and cardiac performance. 
In contrast, AAS administration, combined with physical 
training, has been reported to prevent cardiac hypertrophy 
in dogs submitted to endurance training (Moore, 1998). 
The cardiac remodeling associated with the use of 
AAS alters ventricular function, resulting in cardiovas-
cular disease (Woodiwiss et al., 2000; Kasikcioglu et al., 
2008). This remodeling induced by physical activity is 
usually considered beneficial physiologically, because it 
improves cardiac metabolism, ventricular structure and 
blood flow (Moore, 1998). Chronic cardiovascular disease 
due to cardiac remodeling is considered pathological and 
is characterized by, among others features, changes in cell 
size and metabolism (Aeschbacher et al., 2001). 
In relation to the liver, studies have shown that cli-
nical subchronic treatment with Nandrolone Decanoate at 
high doses promotes deleterious effects to the liver (Vieira 
et al., 2008). In our results, although no significant diffe-
rences in adjusted body weight of the animals was noted, 
we stress the intense periportal hepatic congestion found 
in 62.5% (5 rats) of the animals in the trained group treated 
with TU, and in 50% of the sedentary group of animals 
treated with TU.  Outbreaks of isolated hepatic necrosis 
without inflammatory response were also observed in 
62.5% of trained and sedentary groups treated with TU. 
Absent inflammatory response at analyzed necrotic sites 
is atypical, since this response represents a physiologic at-
tempt to remove dead cells. The effects of chronic use and 
abuse of AAS in the liver, serum lipids and the reproduc-
tive system are well documented (Hartgens et al., 2004). 
Accordingly, chronic use of AAS leads to structural and 
functional changes in the liver such as cholestatic jaundice, 
M. T. Bento-Silva, M. C. C. Martins, F. L. Torres-Leal, T. L. Barros, I. L. N. F. Carvalho, H. A. Carvalho Filho, F. R. C. Almeida86
peliotic hepatic hyperplasia and hepatocellular adenomas 
(Fortunato et al., 2006). Moreover, Boada et al. (1999) 
observed that rats treated with high doses of Stanozolol 
showed inflammation or degeneration of the central lobe of 
the liver, a change which is proliferant in all hepatocytes. 
Burghardt et al. (2004) studied the effects of chro-
nic treadmill training on behavioral parameters in rats 
and concluded that the exploratory locomotor activity, 
assessed using the open field method, was reduced af-
ter training. As for prolonged use of AAS in females, it 
was associated with decreased locomotor activity and 
increased aggression, a finding explained by increased 
depressive behavior (Bronson et al., 1996). The increase 
in aggressive behavior was also associated with decreased 
amount of serotonin (5-HT) in rats that were chronically 
treated with AAS (Keleti et al., 2007; Kubala et al., 2008). 
In our study, rats treated with TU associated with physical 
training showed a decrease in exploratory motor activity, 
assessed using the open-corroborating data from the litera-
ture. However, physical training (or single treatment with 
TU) alone proved  unable to promote change in locomotor 
exploratory behavior. 
In conclusion, the chronic use of TU associated with 
moderately intense physical training for 4 weeks, causes 
an increase in body weight, as well as increased relative 
weight of the heart and kidneys. In the liver, TU promo-
ted histological changes ranging from hepatic necrosis 
to periportal congestion. The reproductive system of rats 
was altered by chronic use of TU, through interruption of 
the estrous cycle and ovarian atrophy. TU associated with 
exercise also reduced exploratory motor activity.
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